579 results
Page 13 of 29
6-K
EX-99.1
0n1gl5
8 May 13
Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder
12:00am
6-K
EX-99.1
bst6fuuyk16u8
2 May 13
Teva Reports First Quarter 2013 Results
12:00am
6-K
qwmirte n4de
2 May 13
Current report (foreign)
12:00am
6-K
EX-99.1
2y3mcnta641ea5
1 May 13
FDA Approves Over-The-Counter Availability of Plan B One-Step® (levonorgestrel) tablet 1.5 mg for Consumers 15 and Over
12:00am
6-K
EX-99.1
hp5b0q4pq
29 Apr 13
Live Filing
12:00am
6-K
EX-99.1
vxlzeqy
25 Apr 13
Live Filing
12:00am
6-K
EX-99.1
jfv8tt0q76
23 Apr 13
Teva and Xenon Announce FDA Orphan Drug Designation for Pain Drug XEN402
12:00am
6-K
EX-99.1
0cv34pi 8aks9
17 Apr 13
Data Reported Comparable Multiple Pregnancy Rates Among Patients Treated with Investigational Milprosa™ and Progesterone Vaginal Gel
12:00am
6-K
EX-99.1
r3tkk82f8xio5v 4jb
8 Apr 13
Teva-Handok Names Yoo Suk Hong as Chief Executive Officer
12:00am
6-K
EX-99.1
xc7 l2p8vz
8 Apr 13
Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan
12:00am
6-K
EX-99.1
9tx5sa3g
29 Mar 13
Live Filing
12:00am
6-K
EX-99.1
mnfv71lgp 1cjf8
21 Mar 13
Live Filing
12:00am
6-K
EX-99.1
zti 1vldxi3
20 Mar 13
Live Filing
12:00am
6-K
EX-99.1
n2sw3gn
14 Mar 13
Teva to Present New Research on CNS Product Portfolio and Pipeline at 2013 American Academy of Neurology Annual Meeting
12:00am
6-K
EX-99.1
zl5r503t
8 Mar 13
Teva Files 2012 Annual Report on Form 20-F
12:00am
6-K
EX-99.1
76g08nn2r7td
6 Mar 13
Live Filing
12:00am
6-K
EX-99.1
y7xx9 hpmzxoccs7
4 Mar 13
Live Filing
12:00am
6-K
EX-99.1
emgqtsu4id lik9
22 Feb 13
Additional QNASL® (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting
12:00am
6-K
EX-99.1
sgdor5nsmmyq8aamm
14 Feb 13
Live Filing
12:00am